'Reuptake inhibitors' diaporamas de présentation

MENTAL HEALTH NURSING Susan Hench, RN, MS Nursing 101

1.94k views • 148 slides

AFFECTIVE DISORDERS

AFFECTIVE DISORDERS. UNIPOLAR DISORDER ~ Major Depression BIPOLAR DISORDER ~ Depression and Mania. SYMPTOMS OF DEPRESSION. ANHEDONIA ~ lack of pleasure Feelings of WORTHLESSNESS PSYCHOMOTOR RETARDATION Loss of ENERGY (FATIGUE) VEGETATIVE SYMPTOMS appetite disturbances

890 views • 62 slides

Toxicology Program Psychiatric drug poisoning

Toxicology Program Psychiatric drug poisoning. Dr HT Fung TMH AED 15 Jun 2005. F/18. Depression DO Confused BP 101/62 P 143 Pupils 5 mm NR. Poison DDx? Mechanism? Tx?. QRS 0.1 s QTc 0.58 s. BP 90/60, why?. - ? conduction -? inotropy -?1 block NE depletion -Adenosine

699 views • 46 slides

Current Topics in Neuropsych Research

Current Topics in Neuropsych Research. June 28, 2011. Current Research in Epilepsy & Depression. Seizure Susceptibility in a Rodent Model of Depression & Epilepsy Co-Morbidity. S. Alisha Epps Emory University Dept of Human Genetics Neuroscience Program Weinshenker Lab.

571 views • 44 slides

Chapter 14

532 views • 37 slides

CHANGING CONCEPTIONS OF MENTAL ILLNESS

CHANGING CONCEPTIONS OF MENTAL ILLNESS. CONCEPTIONS OF MENTAL ILLNESS. HOW VIEWS OF MENTAL ILLNESS HAVE CHANGED OVER TIME CURRENT CONCEPTIONS OF MENTAL ILLNESS WHERE DRAW THE LINE BETWEEN MENTAL ILLNESS AND NORMALITY?. PRE 20TH CENTURY. PRE-20TH CENTURY. MENTAL ILLNESS IS UNIVERSAL

687 views • 36 slides

Treatment of Disorders

436 views • 31 slides

Pharmacology of antidepressants and mood stabilisers

Pharmacology of antidepressants and mood stabilisers. Dr Caroline Stewart c.a.stewart@dundee.ac.uk. Learning Outcomes. List the main classes of antidepressant drug Describe the effects of antidepressant drugs on synaptic monoamine levels

1.02k views • 31 slides

ANTIDEPRESSANTS

ANTIDEPRESSANTS. New Antidepressants. Fluoxetine Fluvoxamine Citalopram Sertraline Paroxetine . Selective Serotonin Reuptake Inhibitors SSRIs. Venalafaxine. Serotonin Norepinephrine Reuptake Inhibitors SNRIs. Reboxetine. Norepinephrine Reuptake Inhibitors (NRIs).

693 views • 28 slides

DEPRESSION

DEPRESSION. Alex Padikken 4 th Year Pharmacy Student Florida A&M University Disease State presentation. Objective. Define Depression Discuss the signs and symptoms Discuss risk factors, prevalence and pathophysiology Describe the components of diagnosis and treatment options. .

1.17k views • 27 slides

Depression

370 views • 23 slides

ANTIDEPRESSANTS

ANTIDEPRESSANTS. New Antidepressants. Selective Serotonin Reuptake Inhibitors. Serotonin Norepinephrine Reuptake Inhibitors. SSRIs. Tetracyclic Antidepressants. SNRIs. Venalafaxine Nefazodone. TeCAs. Fluoxetine Fluvoxamine Sertraline Paroxetine Citalopram. Trazodone Mianserin

721 views • 20 slides

Chapter 35

Chapter 35. Management of Anxiety Disorders. Anxiety. An uncomfortable state with psychologic and physical components Characterized by fear, apprehension, dread, and uneasiness Among the most common psychiatric illnesses. Types of Anxiety Disorders. Generalized anxiety disorder

260 views • 14 slides

Antidepressant Drugs Market Analysis and In-depth Research on Market Size

Depression affects a person's thoughts, behavior, feelings and sense of well-being and is caused due to biological, genetics, environment, and psychological factors. The symptoms usually include low mood and aversion to physical activity. Depression is more common in women than men. Depression drugs works by fixing chemical imbalance such as lack of serotonin in the brain. Read more: https://prn.to/2BP3cJ0

86 views • 8 slides

Antidepressant Drugs Market Expected to Reach $15,983 Million by 2023

The antidepressant drugs market accounted for $13,755 million in 2016, and is estimated to reach $15,983 million by 2023, registering a CAGR of 2.1% from 2017 to 2023

82 views • 6 slides